129 related articles for article (PubMed ID: 31372841)
1. High expression of soluble CD155 in estrogen receptor-negative breast cancer.
Iguchi-Manaka A; Okumura G; Ichioka E; Kiyomatsu H; Ikeda T; Bando H; Shibuya A; Shibuya K
Breast Cancer; 2020 Jan; 27(1):92-99. PubMed ID: 31372841
[TBL] [Abstract][Full Text] [Related]
2. Increased Soluble CD155 in the Serum of Cancer Patients.
Iguchi-Manaka A; Okumura G; Kojima H; Cho Y; Hirochika R; Bando H; Sato T; Yoshikawa H; Hara H; Shibuya A; Shibuya K
PLoS One; 2016; 11(4):e0152982. PubMed ID: 27049654
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived soluble CD155 inhibits DNAM-1-mediated antitumor activity of natural killer cells.
Okumura G; Iguchi-Manaka A; Murata R; Yamashita-Kanemaru Y; Shibuya A; Shibuya K
J Exp Med; 2020 Mar; 217(4):1. PubMed ID: 32040157
[TBL] [Abstract][Full Text] [Related]
4. Identification of secreted CD155 isoforms.
Baury B; Masson D; McDermott BM; Jarry A; Blottière HM; Blanchardie P; Laboisse CL; Lustenberger P; Racaniello VR; Denis MG
Biochem Biophys Res Commun; 2003 Sep; 309(1):175-82. PubMed ID: 12943679
[TBL] [Abstract][Full Text] [Related]
5. High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.
Jin AL; Yang YH; Su X; Yang WJ; Liu T; Chen W; Li T; Ding L; Wang H; Wang BL; Pan BS; Zhou J; Fan J; Yang XR; Guo W
J Clin Lab Anal; 2022 Mar; 36(3):e24259. PubMed ID: 35089611
[TBL] [Abstract][Full Text] [Related]
6. CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration.
Triki H; Charfi S; Bouzidi L; Ben Kridis W; Daoud J; Chaabane K; Sellami-Boudawara T; Rebai A; Cherif B
Life Sci; 2019 Aug; 231():116543. PubMed ID: 31176775
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma.
Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G
Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020
[TBL] [Abstract][Full Text] [Related]
8. Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells.
Mantovani S; Varchetta S; Mele D; Maiello R; Donadon M; Soldani C; Franceschini B; Torzilli G; Tartaglia G; Maestri M; Piccolo G; Barabino M; Opocher E; Bernuzzi S; Mondelli MU; Oliviero B
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011052
[TBL] [Abstract][Full Text] [Related]
9. Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155.
Takahashi N; Sugaya M; Suga H; Oka T; Kawaguchi M; Miyagaki T; Fujita H; Inozume T; Sato S
J Invest Dermatol; 2017 Aug; 137(8):1766-1773. PubMed ID: 28395975
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation.
Fionda C; Abruzzese MP; Zingoni A; Soriani A; Ricci B; Molfetta R; Paolini R; Santoni A; Cippitelli M
BMC Cancer; 2015 Jan; 15():17. PubMed ID: 25609078
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of LRP16 gene in human breast cancer].
Liao DX; Han WD; Zhao YL; Pu YD; Mu YM; Luo CH; Li XH
Ai Zheng; 2006 Jul; 25(7):866-70. PubMed ID: 16831279
[TBL] [Abstract][Full Text] [Related]
13. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
14. CD155 expression and its prognostic value in postoperative patients with breast cancer.
Yong H; Cheng R; Li X; Gao G; Jiang X; Cheng H; Zhou X; Zhao W
Biomed Pharmacother; 2019 Jul; 115():108884. PubMed ID: 31035013
[TBL] [Abstract][Full Text] [Related]
15. A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.
Miglietta L; Morabito F; Provinciali N; Canobbio L; Meszaros P; Naso C; Murialdo R; Boitano M; Salvi S; Ferrarini M
Eur J Surg Oncol; 2013 Oct; 39(10):1046-52. PubMed ID: 23890870
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
[TBL] [Abstract][Full Text] [Related]
17. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
Front Immunol; 2020; 11():40. PubMed ID: 32082316
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the CD155 gene in human colorectal carcinoma.
Masson D; Jarry A; Baury B; Blanchardie P; Laboisse C; Lustenberger P; Denis MG
Gut; 2001 Aug; 49(2):236-40. PubMed ID: 11454801
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.
de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP
J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]